biote Statistics
Total Valuation
biote has a market cap or net worth of $115.98 million. The enterprise value is $194.34 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 45.66 million shares outstanding. The number of shares has increased by 10.63% in one year.
| Current Share Class | 32.27M |
| Shares Outstanding | 45.66M |
| Shares Change (YoY) | +10.63% |
| Shares Change (QoQ) | +15.64% |
| Owned by Insiders (%) | 28.27% |
| Owned by Institutions (%) | 41.98% |
| Float | 16.32M |
Valuation Ratios
The trailing PE ratio is 3.26 and the forward PE ratio is 11.04.
| PE Ratio | 3.26 |
| Forward PE | 11.04 |
| PS Ratio | 0.43 |
| Forward PS | 0.59 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.37 |
| P/OCF Ratio | 2.90 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 4.99, with an EV/FCF ratio of 5.65.
| EV / Earnings | 6.75 |
| EV / Sales | 0.99 |
| EV / EBITDA | 4.99 |
| EV / EBIT | 5.21 |
| EV / FCF | 5.65 |
Financial Position
The company has a current ratio of 1.01
| Current Ratio | 1.01 |
| Quick Ratio | 0.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.68 |
| Debt / FCF | 3.09 |
| Interest Coverage | 3.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 21.95% |
| Return on Invested Capital (ROIC) | 128.12% |
| Return on Capital Employed (ROCE) | 67.85% |
| Revenue Per Employee | $901,590 |
| Profits Per Employee | $132,691 |
| Employee Count | 217 |
| Asset Turnover | 1.84 |
| Inventory Turnover | 2.88 |
Taxes
| Income Tax | -1.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.53% in the last 52 weeks. The beta is 1.15, so biote's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -57.53% |
| 50-Day Moving Average | 2.84 |
| 200-Day Moving Average | 3.55 |
| Relative Strength Index (RSI) | 43.51 |
| Average Volume (20 Days) | 142,980 |
Short Selling Information
The latest short interest is 971,739, so 2.13% of the outstanding shares have been sold short.
| Short Interest | 971,739 |
| Short Previous Month | 894,137 |
| Short % of Shares Out | 2.13% |
| Short % of Float | 5.96% |
| Short Ratio (days to cover) | 9.23 |
Income Statement
In the last 12 months, biote had revenue of $195.65 million and earned $28.79 million in profits. Earnings per share was $0.78.
| Revenue | 195.65M |
| Gross Profit | 141.58M |
| Operating Income | 37.33M |
| Pretax Income | 30.76M |
| Net Income | 28.79M |
| EBITDA | 38.99M |
| EBIT | 37.33M |
| Earnings Per Share (EPS) | $0.78 |
Full Income StatementBalance Sheet
The company has $28.05 million in cash and $106.41 million in debt, giving a net cash position of -$78.36 million or -$1.72 per share.
| Cash & Cash Equivalents | 28.05M |
| Total Debt | 106.41M |
| Net Cash | -78.36M |
| Net Cash Per Share | -$1.72 |
| Equity (Book Value) | -65.47M |
| Book Value Per Share | -2.37 |
| Working Capital | 815,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $39.99 million and capital expenditures -$5.61 million, giving a free cash flow of $34.39 million.
| Operating Cash Flow | 39.99M |
| Capital Expenditures | -5.61M |
| Free Cash Flow | 34.39M |
| FCF Per Share | $0.75 |
Full Cash Flow StatementMargins
Gross margin is 72.37%, with operating and profit margins of 19.08% and 14.72%.
| Gross Margin | 72.37% |
| Operating Margin | 19.08% |
| Pretax Margin | 15.72% |
| Profit Margin | 14.72% |
| EBITDA Margin | 19.93% |
| EBIT Margin | 19.08% |
| FCF Margin | 17.58% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.63% |
| Shareholder Yield | -10.63% |
| Earnings Yield | 24.83% |
| FCF Yield | 29.65% |
Analyst Forecast
The average price target for biote is $6.00, which is 136.22% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 136.22% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 7.46% |
| EPS Growth Forecast (5Y) | 69.10% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.54 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.54 |
| Piotroski F-Score | 7 |
